NBIX NEUROCRINE BIOSCIENCES INC

NEUTRAL Impact: 2/10 Insider Cluster (3 insiders)
Horizon immediate Filed Jun 2, 2026 Processed 3d ago
Insider cluster: 3 insiders, $2.7M total

Price Chart

Loading chart...

Executive Summary

Three NBIX insiders, including the Chief Scientific Officer, sold a combined $2.67M in open-market shares over a 4-day window. All sales were preceded by option exercises at zero or low cost, indicating routine cashless exercises rather than opportunistic bearish bets. The total value represents ~0.016% of NBIX's $16.2B market cap — a trivial amount with no material signaling value.

Key Financial Metrics

Direction
selling
Total Value
$2.7M
Insiders
3

Actionable Insight

This cluster is routine and non-informative. The sales are small relative to market cap, all tied to option exercises, and consistent with standard cashless exercise patterns. No bearish signal. Monitor the next 8-K or earnings release for any fundamental changes, but this filing alone does not warrant action.

Key Facts

  • Three insiders sold a total of $2.67M in open-market shares between May 26-29, 2026
  • Chief Scientific Officer Onyia Jude sold $1.71M (11,000 shares at $155.53) after exercising options at $84.74
  • Chief Corp. Affairs Officer Boyer David W. sold $609K (3,890 shares at $156.64)
  • Chief Regulatory Officer Delaet Ingrid sold $354K (2,261 shares at $156.71) after exercising options at $79.02
  • Total sales equal ~0.016% of NBIX's $16.2B market cap — well below the 0.1% materiality threshold
  • All sales were preceded by option exercises, consistent with routine cashless exercises for tax/vesting purposes
  • No open-market purchases were made by any insider during the window

Financial Impact

$2.67M in insider sales, representing 0.016% of market cap

insider holdings

Risk Factors

  • Insiders may continue selling if the stock appreciates further, but no evidence of coordinated bearish view
  • No purchases to offset the selling — but the dollar amounts are too small to infer negative sentiment

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (36 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NBIX-1780437825000
11 reports for NBIX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NBIX — sortable, filterable
Type Now
Jun 4, 2026
1d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
Jun 2, 2026
3d ago
Insider Cluster
NEUTRAL ★ 2/10
$164.23 $166.83▲ +1.58%▲ +1.18%$163.88 (−0.21%)
Jun 2, 2026
3d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
Jun 2, 2026
3d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+1
May 29, 2026
7d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 28, 2026
8d ago
Insider Cluster
NEUTRAL ★ 4/10
awaiting T+1
May 21, 2026
15d ago
Insider Cluster
NEUTRAL ★ 4/10
awaiting T+1
May 21, 2026
15d ago
Insider Cluster
BEARISH ★ 5/10
awaiting T+1
May 18, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 18, 2026
18d ago
8-K
BULLISH ★ 7/10
awaiting T+1
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (39h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access